83
Participants
Start Date
March 14, 2005
Primary Completion Date
April 13, 2007
Study Completion Date
April 13, 2007
C1 esterase inhibitor [human] (C1INH-nf)
Placebo (saline)
Mount Sinai School of Medicine, New York
Montefiore Medical Center, The Bronx
Winthrop University Hospital, Mineola
Penn State University, Hershey
Institute for Asthma and Allergy, Wheaton
Virginia Adult and Pediatric Allergy and Asthma, Richmond
Duke University Medical Center, Durham
Allergy Partners of the Upstate, Greenville
Family Allergy and Asthma Center, Atlanta
Orlando Regional Healthcare, Orlando
Allergy and Asthma Center, Fort Lauderdale
Clinical Research Consultants, Inc, Hoover
Optimed Research, Columbus
Bernstein Clinical Research, Cincinnati
Welborn Clinic Allergy and Immunology, Evansville
Grand Traverse Allergy, Traverse City
University of Iowa Hospital and Clinic, Iowa City
Allergy, Asthma and Pulmonary Clinical Research, Madison
MeritCare Clinical Research, Fargo
St. Louis University School of Medicine, St Louis
The Baton Rouge Clinic, AMC, Baton Rouge
Allergy Clinic of Tulsa, Tulsa
AARA Research Center, Dallas
Baylor College of Medicine, Houston
Allergy and Asthma Research Center, San Antonio
Allergy and Immunology Associates, Scottsdale
Nevada Access to Research and Education Society, Las Vegas
UCLA-David Geffen School of Medicine, Los Angeles
Allergy and Asthma Clinical Research, Inc, Walnut Creek
Allergy Asthma and Dermatology Research Center, Lake Oswego
Puget Sound Allergy, Asthma and Immunology, Tacoma
Marycliff Allergy Specialists, Spokane
University of California, San Diego, San Diego
Allergy Asthma and Immunology, Falmouth
University of Massachusetts Medical School, Worcester
UMDNJ Asthma and Allergy Research Center, Newark
University of Texas Medical Branch, Galveston
Lead Sponsor
Shire
INDUSTRY